Viewing Study NCT00120393


Ignite Creation Date: 2025-12-25 @ 12:56 AM
Ignite Modification Date: 2026-01-24 @ 8:45 PM
Study NCT ID: NCT00120393
Status: COMPLETED
Last Update Posted: 2010-02-05
First Post: 2005-07-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir
Sponsor: Bristol-Myers Squibb
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: AI424-100
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Study Director
Old Organization: Bristol-Myers Squibb

Collaborators